• β-Elemene Suppresses Adipogenesis via AMPK Pathway in 3T3-L1

  2026-07-02

  This study reveals that β-elemene inhibits adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, countering both lipid accumulation and insulin resistance. These findings offer mechanistic insights for leveraging β-elemene in metabolic disease models and highlight its translational relevance in obesity research.

• Ac-YVAD-CMK: Optimizing Pyroptosis Inhibition in Liver Model

  2026-07-01

  Ac-YVAD-CMK (N-Ac-Tyr-Val-Ala-Asp-CMK) enables precise, selective caspase-1 inhibition, powering advanced dissection of inflammatory cell death in hepatic infection models. This guide delivers updated workflows, troubleshooting, and practical insights directly informed by TMEM16F-Kupffer cell research, maximizing the clarity and reproducibility of inflammasome studies.

• Birinapant (TL32711): Applied Workflows for Apoptosis Induct

  2026-07-01

  Birinapant (TL32711) enables precise antagonism of inhibitor of apoptosis proteins, unlocking robust apoptosis induction in cancer research. This article delivers stepwise protocol guidance, troubleshooting tips, and practical insights for translational workflows—especially in overcoming chemoradiotherapy resistance in colorectal cancer models.

• Exo1: Mechanistic Precision for Advanced Exocytic Pathway Re

  2026-06-30

  Explore Exo1 (methyl 2-(4-fluorobenzamido)benzoate) as a uniquely selective tool for dissecting membrane trafficking and exocytic pathways. This in-depth analysis reveals nuanced applications, mechanistic advantages, and new insights for optimizing exocytosis assays.

• Z-IETD-FMK (SKU B3232): Optimizing Caspase-8 Inhibition in C

  2026-06-30

  This article provides an evidence-driven exploration of Z-IETD-FMK (SKU B3232) as a specific caspase-8 inhibitor for apoptosis and immune signaling research. Through scenario-based Q&A, we address common laboratory challenges in assay design, data interpretation, and product selection—highlighting how APExBIO’s Z-IETD-FMK ensures reproducibility, workflow compatibility, and validated performance.

• Müller Cell PEDF and Angiopoietin Signaling in Retinal Neuro

  2026-06-29

  This study uncovers how Müller cell-derived pigment epithelium-derived factor (PEDF) and angiopoietin signaling jointly regulate retinal neuron survival through Tie-2-PI3K/Akt pathways. The findings provide mechanistic insight into neurovascular interactions in the retina, suggesting new experimental avenues for neuroprotection and anti-angiogenic strategies in ischemic and degenerative eye diseases.

• RSL3: A Glutathione Peroxidase 4 Inhibitor Empowering Ferrop

  2026-06-29

  RSL3, a benchmark glutathione peroxidase 4 inhibitor, unlocks precise ferroptosis induction and synthetic lethality in RAS-driven cancer models. This guide delivers actionable protocols, troubleshooting wisdom, and interpretation strategies grounded in the latest lipid peroxidation and membrane biology advances.

• Birinapant (TL32711): Applied Protocols for Cancer Apoptosis

  2026-06-28

  Birinapant (TL32711) delivers high-fidelity apoptosis induction through targeted IAP antagonism, enabling precise modulation of cell death in cancer models. This article details experimental workflows, troubleshooting strategies, and translational guidance for maximizing data quality in chemoradiotherapy sensitivity studies.

• Z-VAD-FMK: Pan-Caspase Inhibitor for Apoptosis Pathway Analy

  2026-06-27

  Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor widely used as a tool in apoptosis pathway research. Its mechanism prevents the activation of caspase-3 and related proteases, making it indispensable for dissecting apoptotic versus non-apoptotic cell death in cancer and immunology models. APExBIO’s A1902 formulation offers high solubility and validated performance for in vitro and in vivo applications.

• Prednisolone: Synthetic Glucocorticoid for Inflammation Modu

  2026-06-26

  Prednisolone, a synthetic glucocorticoid, is a high-purity research tool for investigating glucocorticoid receptor signaling and inflammation modulation. Its well-characterized solubility and storage parameters ensure reproducibility in immunology research. Recent studies highlight its integration into advanced degradation workflows targeting transmembrane proteins.

• TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas

  2026-06-26

  Zhou et al. uncover a novel pathway driving bone metastasis in prostate cancer, showing that TSPAN18 stabilizes STIM1 by blocking its ubiquitination by TRIM32. This mechanism enhances calcium signaling and metastatic progression, offering new targets for hormone-responsive cancer research.

• Iptacopan (LNP023): Applied Workflows for Complement Inhibit

  2026-06-25

  Iptacopan (LNP023) enables precise, reversible inhibition of the alternative complement pathway, unlocking robust experimental control in both cellular assays and animal models. This article guides researchers through optimized workflows, comparative advantages, and practical troubleshooting strategies, grounded in clinical and preclinical evidence.

• Lipid Scrambling Suppresses Ferroptosis and Promotes Tumor I

  2026-06-25

  Yang et al. (2025) demonstrate that TMEM16F-mediated lipid scrambling at the plasma membrane critically inhibits ferroptosis by redistributing phospholipids and reducing membrane tension. Their findings reveal a new mechanistic link between membrane lipid dynamics and tumor immune rejection, highlighting a potential therapeutic target for enhancing cancer immunotherapy.

• Apicidin as a Histone Deacetylase Inhibitor: Applied Workflo

  2026-06-24

  Apicidin unlocks precise epigenetic modulation, making it invaluable for cancer biology and reproductive toxicology. Discover how to optimize experimental workflows, troubleshoot solubility, and leverage the latest reference findings for robust, reproducible outcomes.

• Antimycin A4: Unveiling Mechanistic Precision in Metabolic A

  2026-06-23

  Explore how Antimycin A4, a potent ATP-citrate lyase inhibitor, advances metabolic research through precise dual-pathway inhibition. This article uniquely dissects mechanistic selectivity, structural considerations, and best practices for mitochondrial and lipid biosynthesis studies.

3573 records 7/239 page Previous Next First page 上5页 678910 下5页 Last page